首页> 外文期刊>Therapeutic advances in respiratory disease. >C-reactive protein, procalcitonin, D-dimer, and ferritin in severe coronavirus disease-2019: a meta-analysis
【24h】

C-reactive protein, procalcitonin, D-dimer, and ferritin in severe coronavirus disease-2019: a meta-analysis

机译:C-反应蛋白,ProCalcitonin,D-二聚体和重度冠状病毒疾病中的铁蛋白 - 2019年:Meta分析

获取原文
           

摘要

Background: Patients critically ill with coronavirus disease-2019 (COVID-19) feature hyperinflammation, and the associated biomarkers may be beneficial for risk stratification. We aimed to investigate the association between several biomarkers, including serum C-reactive protein (CRP), procalcitonin (PCT), D-dimer, and serum ferritin, and COVID-19 severity. Methods: We performed a comprehensive systematic literature search through electronic databases. The outcome of interest for this study was the composite poor outcome, which comprises mortality, acute respiratory distress syndrome, need for care in an intensive care unit, and severe COVID-19. Results: A total of 5350 patients were pooled from 25 studies. Elevated CRP was associated with an increased composite poor outcome [risk ratio (RR) 1.84 (1.45, 2.33), p? 2 : 96%] and its severe COVID-19 (RR 1.41; I 2 : 93%) subgroup. A CRP??10?mg/L has a 51% sensitivity, 88% specificity, likelihood ratio (LR) of 4.1, LR- of 0.5, and an area under curve (AUC) of 0.84. An elevated PCT was associated with an increased composite poor outcome [RR 3.92 (2.42, 6.35), p? 2 : 85%] and its mortality (RR 6.26; I 2 : 96%) and severe COVID-19 (RR 3.93; I 2 : 63%) subgroups. A PCT??0.5?ng/ml has an 88% sensitivity, 68% specificity, LR of 2.7, LR- of 0.2, and an AUC of 0.88. An elevated D-dimer was associated with an increased composite poor outcome [RR 2.93 (2.14, 4.01), p? 2 : 77%], including its mortality (RR 4.15; I 2 : 83%) and severe COVID-19 (RR 2.42; I 20.5?mg/L has a 58% sensitivity, 69% specificity, LR of 1.8, LR- of 0.6, and an AUC of 0.69. Patients with a composite poor outcome had a higher serum ferritin with a standardized mean difference of 0.90 (0.64, 1.15), p? 2 : 76%. Conclusion: This meta-analysis showed that an elevated serum CRP, PCT, D-dimer, and ferritin were associated with a poor outcome in COVID-19. The reviews of this paper are available via the supplemental material section.
机译:背景:患者与冠状病毒疾病-109(Covid-19)具有危重症状的患者具有高炎症,并且相关的生物标志物可能有利于风险分层。我们的旨在探讨几种生物标志物之间的关联,包括血清C-反应蛋白(CRP),ProCalcitonin(PCT),D-二聚体和血清铁蛋白和Covid-19严重程度。方法:我们通过电子数据库进行了全面的系统文献搜索。本研究兴趣的结果是综合差的结果,包括死亡率,急性呼吸窘迫综合征,需要在重症监护病房和严重的Covid-19中进行护理。结果:25项研究共汇集了5350名患者。升高的CRP与综合差的结果增加有关[风险比(RR)1.84(1.45,2.33),p? 2:96%]及其严重的Covid-19(RR 1.41; I 2:93%)子组。 CRP ?? 10?Mg / L有51%的灵敏度,88%的特异性,似然比(LR)为4.1,lr-0.5,曲线(AUC)为0.84。升高的PCT与增加的复合差的结果增加相关[RR 3.92(2.42,6.35),p? 2:85%]及其死亡率(RR 6.26; I 2:96%)和严重的Covid-19(RR 3.93; I 2:63%)亚组。 PCT ?? 0.5?Ng / ml具有88%的灵敏度,68%特异性,LR为2.7,LR-0.2和0.88的AUC。升高的D-二聚体与综合较差的结果增加相关[RR 2.93(2.14,4.01),p? 2:77%],包括其死亡率(RR 4.15; I 2:83%)和严重的Covid-19(RR 2.42; I 20.5?Mg / L有58%的灵敏度,69%,LR为1.8,LR- 0.6和0.69的AUC。综合较差结果的患者具有更高的血清铁蛋白,标准化平均差异为0.90(0.64,15),P?2:76%。结论:该元分析显示升高血清CRP,PCT,D-二聚体和铁蛋白与Covid-19中的较差的结果有关。本文的审查可通过补充材料部分获得。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号